Welcome to eviQ
A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.
We are pleased to circulate an FAQ relating to the newly licenced COVID-19 vaccines for chemotherapy patients. This FAQ has been adopted by the UK Chemotherapy board and endorsed by BOPA, UKONs, ACP, RCR, RCPath and the RCP
Expressions of interest are invited from members of the eviQ Radiation Oncology Reference Committee for the position of eviQ Radiation Oncology Reference Committee Co-Chair.
Given the continuing challenges raised by COVID-19, all eviQ reference committee meetings in 2021 will be held virtually with a preferred videoconference option. View all dates via link.
eviQ Education are in the process of mapping out our cancer eLearning resources for the year and we want your input!
Now is your chance to tell us exactly how we can support your learning in 2021 – what you like, how you like it and anything you want to put on our radar.